Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
DexCom (DXCM) Soars 9.8%: Is Further Upside Left in the Stock?
04:46am, Thursday, 07'th Mar 2024
DexCom (DXCM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road
S&P 500 Gains and Losses Today: Dexcom Soars as FDA Approves New Glucose Monitor
05:40pm, Wednesday, 06'th Mar 2024
Major U.S. equities indexes advanced after Federal Reserve Chair Jerome Powell testified in Congress that the central bank is still likely to cut interest rates at some point in 2024.
Final Trades: SL Green, Palantir and Dexcom
02:00pm, Wednesday, 06'th Mar 2024
The Investment Committee share their Final Trades.
DexCom's (DXCM) Stelo Glucose Biosensor Receives FDA Approval
09:46am, Wednesday, 06'th Mar 2024
DexCom's (DXCM) Stelo receives FDA clearance, which makes it the first FDA-approved glucose biosensor to be available over the counter.
DexCom (DXCM) Rises As Market Takes a Dip: Key Facts
07:01pm, Monday, 04'th Mar 2024
In the most recent trading session, DexCom (DXCM) closed at $122.30, indicating a +0.46% shift from the previous trading day.
3 Telehealth Stocks With Room to Run in 2024
01:53pm, Thursday, 29'th Feb 2024
While telehealth stocks, once stars of the pandemic era, have seen a recent dip in investor interest, savvy investors recognize the sector's bright future. Moreover, according to TalkSpace (NASDAQ: TA
Is DexCom (DXCM) a Buy as Wall Street Analysts Look Optimistic?
10:31am, Tuesday, 27'th Feb 2024
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Here is What to Know Beyond Why DexCom, Inc. (DXCM) is a Trending Stock
10:00am, Friday, 23'rd Feb 2024
Zacks.com users have recently been watching DexCom (DXCM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Got $1,000? Buy These Hot Growth Stocks Before They Take Off
09:53am, Thursday, 22'nd Feb 2024
ResMed makes medical devices for sleep apnea and COPD, a potential market of over a billion people. DexCom is a market leader in continuous glucose monitoring devices for diabetes patients.
Tiger Global slashes stakes in Magnificent Seven while piling into semiconductor makers
05:06am, Thursday, 15'th Feb 2024
Tiger Global has slashed its positions in four of the five Magnificent Seven tech stocks that account for almost half of its portfolio, while upping its stake in Amazon.com and piling into semiconduct
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
02:43pm, Wednesday, 14'th Feb 2024
It is entirely fair to state that weight loss treatments have massive transformational power. US FDA approval of weight loss medicines could help shrink millions of waistlines.
Wall Street is surprisingly most bullish on these 3 Nasdaq stocks
08:44am, Wednesday, 14'th Feb 2024
NVIDIA is the best example. After soaring 239% last year, the semiconductor leader is up almost 50% year-to-date.
2 No-Brainer Healthcare Stocks to Buy Right Now
08:30am, Saturday, 10'th Feb 2024
Its essential nature helps the healthcare industry generate more consistent consumer spending. DexCom is raking in profits from its latest product, and it's still looking at a vast long-term opportuni
DexCom (DXCM) Beats on Q4 Earnings, Strong CGM Demand Continues
10:36am, Friday, 09'th Feb 2024
DexCom's (DXCM) fourth-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
DexCom, Inc. (DXCM) Q4 2023 Earnings Call Transcript
09:00pm, Thursday, 08'th Feb 2024
DexCom, Inc. (DXCM) Q4 2023 Earnings Call Transcript
